{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:38:07Z","timestamp":1792269487192,"version":"4.4.0"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>\n                    Ectopic variceal hemorrhage accounts for approximately 5% of all variceal bleeding episodes and represents an uncommon manifestation of portal hypertension. This report describes recurrent parastomal variceal bleeding in a 43-year-old woman with rectal adenocarcinoma who underwent abdominoperineal resection followed by five cycles of oxaliplatin-containing chemotherapy. During chemotherapy, severe hepatocellular injury developed. A liver biopsy performed in June 2020 demonstrated severe interface hepatitis with lymphoplasmacytic portal inflammation, findings that supported a diagnosis of autoimmune hepatitis (AIH). No histopathological features diagnostic of portosinusoidal vascular disease (PSVD) were identified. Subsequently, progressive splenomegaly, gastroesophageal and parastomal varices, and a directly measured portal pressure of 35\u2005cm H\n                    <jats:sub>2<\/jats:sub>\n                    O developed in the absence of established cirrhosis. Inferior mesenteric vein embolization and ultrasound-guided foam sclerotherapy reduced the frequency of recurrent parastomal variceal bleeding but did not achieve complete hemostatic control. Treatment with carvedilol and prednisone was subsequently initiated. The overall clinical presentation was most consistent with multifactorial non-cirrhotic portal hypertension associated with AIH and prior oxaliplatin exposure, with a potential contribution from oxaliplatin-associated sinusoidal or vascular liver injury rather than histologically confirmed PSVD. This case highlights the diagnostic complexity and the need for individualized management in individuals with coexisting autoimmune liver disease, chemotherapy-associated hepatic injury, and refractory ectopic variceal hemorrhage.\n                  <\/jats:p>","DOI":"10.3389\/fmed.2026.1857471","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:26:15Z","timestamp":1788495975000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Autoimmune hepatitis following oxaliplatin exposure presenting with multifactorial non-cirrhotic portal hypertension and recurrent parastomal variceal bleeding"],"prefix":"10.3389","volume":"13","author":[{"given":"Wei","family":"Cheng","sequence":"first","affiliation":[{"name":"Department of Gastrointestinal Surgery, The First Affiliated Hospital of Dali University","place":["Dali, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, The First Affiliated Hospital of Dali University","place":["Dali, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaju","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Gynaecology, The First Affiliated Hospital of Dali University","place":["Dali, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"He","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, The First Affiliated Hospital of Dali University","place":["Dali, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibin","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, The First Affiliated Hospital of Dali University","place":["Dali, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, The First Affiliated Hospital of Dali University","place":["Dali, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Huan","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, The First Affiliated Hospital of Dali University","place":["Dali, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengqin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, The First Affiliated Hospital of Dali University","place":["Dali, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1002\/hep.510280434","article-title":"Management of ectopic varices","volume":"28","author":"Norton","year":"1998","journal-title":"Hepatology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10151-012-0922-6","article-title":"Management of parastomal varices: who re-bleeds and who does not? A systematic review of the literature","volume":"17","author":"Pennick","year":"2013","journal-title":"Tech Coloproctol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1093\/annonc\/mdh095","article-title":"Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer","volume":"15","author":"Rubbia-Brandt","year":"2004","journal-title":"Ann Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1200\/JCO.2009.27.5701","article-title":"Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury","volume":"28","author":"Overman","year":"2010","journal-title":"J Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3816\/CCC.2009.n.038","article-title":"Portal hypertension associated with oxaliplatin administration: clinical manifestations of hepatic sinusoidal injury","volume":"8","author":"Slade","year":"2009","journal-title":"Clin Colorectal Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S2468-1253(19)30047-0","article-title":"Porto-sinusoidal vascular disease: proposal and description of a novel entity","volume":"4","author":"De Gottardi","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/hep.24422","article-title":"Idiopathic noncirrhotic portal hypertension","volume":"54","author":"Schouten","year":"2011","journal-title":"Hepatology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/bjc.2012.590","article-title":"Glutathione S-transferase M1-null genotype as risk factor for SOS in oxaliplatin-treated patients with metastatic colorectal cancer","volume":"108","author":"Vreuls","year":"2013","journal-title":"Br J Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/SLA.0b013e31815774de","article-title":"Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy","volume":"247","author":"Nakano","year":"2008","journal-title":"Ann Surg"},{"key":"B10","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2147\/TCRM.S150968","article-title":"Increase in spleen volume as a predictor of oxaliplatin toxicity","author":"El Chediak","year":"2018","journal-title":"Ther Clin Risk Manag"},{"key":"B11","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ejrad.2017.06.025","article-title":"Diagnostic performance of contrast-enhanced CT-scan in sinusoidal obstruction syndrome induced by chemotherapy of colorectal liver metastases: radio-pathological correlation","volume":"94","author":"Cayet","year":"2017","journal-title":"Eur J Radiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1148\/radiol.2015141749","article-title":"Hepatic parenchymal heterogeneity on contrast-enhanced CT scans following oxaliplatin-based chemotherapy: natural history and association with clinical evidence of sinusoidal obstruction syndrome","volume":"276","author":"Han","year":"2015","journal-title":"Radiology"},{"key":"B13","first-page":"447","article-title":"Splenomegaly and esophageal varices associated with XELOX plus bevacizumab therapy for non-resectable advanced colon cancer: a case report","volume":"60","author":"Yamaguchi","year":"2014","journal-title":"Jpn J Cancer Clin"},{"key":"B14","doi-asserted-by":"publisher","first-page":"990","DOI":"10.4143\/crt.2015.296","article-title":"Splenomegaly and its associations with genetic polymorphisms and treatment outcome in colorectal cancer patients treated with adjuvant FOLFOX","volume":"48","author":"Kim","year":"2016","journal-title":"Cancer Res Treat"},{"key":"B15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1155\/2001\/279637","article-title":"Autoimmune hepatitis: clinical manifestations and diagnostic criteria","volume":"15","author":"McFarlane","year":"2001","journal-title":"Can J Gastroenterol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.jhep.2022.05.033","article-title":"Porto-sinusoidal vascular disorder","volume":"77","author":"De Gottardi","year":"2022","journal-title":"J Hepatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1053\/j.tvir.2013.02.005","article-title":"Stomal varices: management with decompression tips and transvenous obliteration or sclerosis","volume":"16","author":"Saad","year":"2013","journal-title":"Tech Vasc Interv Radiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1055\/s-0037-1598160","article-title":"Stoma complications","volume":"30","author":"Krishnamurty","year":"2017","journal-title":"Clin Colon Rectal Surg"},{"key":"B20","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrgastro.2009.149","article-title":"The clinical use of HVPG measurements in chronic liver disease","volume":"6","author":"Bosch","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.cgh.2007.12.047","article-title":"Bleeding stomal varices: case series and systematic review of the literature","volume":"6","author":"Spier","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1007\/s00270-013-0588-0","article-title":"Alternative treatment for bleeding peristomal varices: percutaneous parastomal embolization","volume":"36","author":"Pabon-Ramos","year":"2013","journal-title":"Cardiovasc Intervent Radiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1111\/j.1572-0241.2000.03211.x","article-title":"Transjugular intrahepatic portosystemic shunt for bleeding stomal varices associated with chronic portal vein occlusion: long-term angiographic, hemodynamic, and clinical follow-up","volume":"95","author":"Morris","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"34857","DOI":"10.18632\/oncotarget.26207","article-title":"Bevacizumab as a chemoprotectant: reducing oxaliplatin induced hepatic sinusoidal injury","volume":"9","author":"Mizrahi","year":"2018","journal-title":"Oncotarget"},{"key":"B25","first-page":"1953","article-title":"Bevacizumab improves splenomegaly and decreases production of hyaluronic acid after L-OHP based chemotherapy","volume":"34","author":"Arakawa","year":"2014","journal-title":"Anticancer Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1093\/jnci\/djx288","article-title":"The addition of bevacizumab to oxaliplatin-based chemotherapy: impact upon hepatic sinusoidal injury and thrombocytopenia","volume":"110","author":"Overman","year":"2018","journal-title":"J Natl Cancer Inst"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1857471\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:26:17Z","timestamp":1788495977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1857471\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":26,"alternative-id":["10.3389\/fmed.2026.1857471"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1857471","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"article-number":"1857471"}}